Herpes Zoster vaccine GSK 1437173A

BIOLOGICAL4 trials

Sponsors

GlaxoSmithKline

Conditions

Herpes ZosterHerpes Zoster Vaccine

Phase 1

Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults

CompletedNCT01086449

GlaxoSmithKlineHerpes Zoster

Start: 2010-03-04End: 2010-11-25Updated: 2018-03-09

Phase 3

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older

CompletedNCT01954251

GlaxoSmithKlineHerpes Zoster

Start: 2013-10-03End: 2015-03-20Updated: 2018-05-02

Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older

CompletedNCT02045836

GlaxoSmithKlineHerpes Zoster, Herpes Zoster Vaccine

Start: 2014-03-05End: 2016-06-17Updated: 2021-05-14

Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older

CompletedNCT02052596

GlaxoSmithKlineHerpes Zoster

Start: 2014-02-07End: 2016-04-21Updated: 2018-04-24

Related Papers

Co-administration of the adjuvanted recombinant zoster vaccine with other adult vaccines: An overview.

2024-02-287 citations

The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged ≥50 years: A randomized trial.

2019-08-2016 citations

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial

Vaccine2018-06-1134 citations

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older

The Journal of Infectious Diseases2017-09-1276 citations